Physician profile
Christopher Park
NPI 1497885339
$7,160.20
in general payments reported to CMS, 2019-2025
31 companies · $4,151 in 2025
The $4,151 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $134 · 2021: $343 · 2022: $291 · 2023: $471 · 2024: $731 · 2025: $4,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,750 · Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,750.00 |
| Food and Beverage | $1,603.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bimini Technologies LLC | $3,750.00 | 2025 | |
| Mentor Worldwide LLC | $832.06 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Merz North America, INC. | $537.14 | 2019-2022 | |
| Allergan, INC. | $352.05 | 2019-2022 | |
| Galderma Laboratories, L.P. | $208.77 | 2019-2025 | Dysport |
| Abbvie INC. | $197.47 | 2023-2025 | |
| Kci USA, INC. | $169.10 | 2019-2022 | |
| Integra Lifesciences Corporation | $166.94 | 2022-2025 | Integra, Omnigraft, Surgimend |
| Tela Bio, INC. | $146.97 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $126.87 | 2019-2024 | Collagenase Santyl, Regranex |
| Polynovo North America LLC | $79.60 | 2024 | Novosorb Btm |
| Organogenesis INC. | $79.52 | 2024 | |
| Kerecis Limited | $77.31 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $68.28 | 2020-2023 | Na |
| Kls-Martin L.P. | $49.53 | 2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $41.19 | 2024-2025 | |
| Motiva USA, LLC | $35.23 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $31.83 | 2019-2023 | Exparel |
| Davol INC. | $24.35 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $19.91 | 2022 | |
| Wright Medical Technology, INC. | $17.80 | 2019 | |
| Tei Biosciences INC | $17.45 | 2019 | |
| Misonix INC | $16.20 | 2019 | |
| Ethicon US, LLC | $16.06 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.81 | 2023 | Seglentis |
| Solventum Corporation | $15.78 | 2024 | Activ.A.C., V.A.C. Veraflo |
| Stryker Corporation | $15.65 | 2025 | Osteoset |
| Zimmer Biomet Holdings, INC. | $15.52 | 2019 | |
| Acera Surgical, INC. | $13.39 | 2019 | |
| Acell, INC. | $13.20 | 2019 | |
| Heraeus Medical, LLC. | $9.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.